Company
Txinno Bioscience Inc.
Txinno Bioscience Inc. has 1 drug tracked on RxWires: 1 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| TXN10128 | Phase 1/2 | NSCLC (Non-small Cell Lung Cancer) |
Latest
No recent events.
Follow Txinno Bioscience Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.